| News

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Newsmaker: Dr. Herbert Zeh III

Email Newsletters

Sign up for one of our email newsletters.
The Alliance for Cancer Gene Therapy has named Dr. Herbert Zeh III, a UPMC surgical oncologist, its 2012 ACGT Investigator. Zeh is receiving a $500,000 grant with the award. That will help him continue his research into gene therapy for pancreatic cancer. His team is looking into how a modified virus can produce hormones that help combat cancer and cancer recurrence.

Daily Photo Galleries

By Adam Smeltz
Thursday, Oct. 18, 2012, 12:01 a.m.

Noteworthy: The Alliance for Cancer Gene Therapy has named Zeh, a surgical oncologist at UPMC, its 2012 ACGT Investigator. A two-year, $500,000 grant from the alliance will support his gene-therapy research to combat pancreatic cancer.

Residence: Hampton

Age: 45

Family: Wife, Kelly; son, Ryan, 20; daughters, Makenzie, 15, and Teegan, 13

Occupation: Chief, Division of Gastrointestinal Surgical Oncology at UPMC CancerCenter; co-director, UPMC Pancreatic Cancer Center and the University of Pittsburgh Cancer Institute GI Oncology Program

Background: For six years, Zeh has co-directed the Pancreatic Cancer Center, one of the largest pancreatic cancer treatment facilities in the United States.

Education: Bachelor's degree in biology and philosophy, 1989, University of Notre Dame; doctorate in medicine, 1994, University of Pittsburgh

Quote: “Unfortunately, still in 2012, most patients who develop this disease will succumb to it. ... It's the highest mountain out there.”

— Adam Smeltz

Subscribe today! Click here for our subscription offers.



Show commenting policy

Most-Read News